Skip to main content
PMC home page
Molecular Pathology : MP logoLink to Molecular Pathology : MP
. 1998 Jun;51(3):138–142. doi: 10.1136/mp.51.3.138

Cytochrome P450 1B1 mRNA in the human central nervous system.

C R Rieder 1, D B Ramsden 1, A C Williams 1
PMCID: PMC395625  PMID: 9850336

Abstract

AIMS: To study the expression of CYP1B1 in a variety of human and rat cell lines as a means of identifying a new tool for the investigation of gene regulation. In addition, to identify the expression of cytochrome P450 1B1 (CYP1B1) in different regions of the central nervous system (CNS). METHODS: Reverse transcription-polymerase chain reaction followed by cloning and sequencing were used to detect the expression of CYP1B1 in human cell lines. Poly A+ mRNA from the human spinal cord and from different brain regions was analysed using a CYP1B1 probe labelled with 32PdCTP. RESULTS: Expression of CYP1B1 was shown in a human astrocytoma cell line (MOG-G-CCM). CYP1B1 mRNA was expressed in a variety of regions of the CNS but with a distinct regional specificity. Expression was highest in the putamen. CONCLUSIONS: The expression of CYP1B1 in a human astrocytoma enables this cell line to be used in further studies of regulation and function of this gene. The demonstration that CYP1B1 mRNA is expressed in a variety of regions of the CNS suggests a role for this gene in brain and spinal cord metabolism. The regional specificity of expression might explain the focal damage of certain human neurodegenerative diseases.

Full Text

The Full Text of this article is available as a PDF (166.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agúndez J. A., Jiménez-Jiménez F. J., Luengo A., Bernal M. L., Molina J. A., Ayuso L., Vázquez A., Parra J., Duarte J., Coria F. Association between the oxidative polymorphism and early onset of Parkinson's disease. Clin Pharmacol Ther. 1995 Mar;57(3):291–298. doi: 10.1016/0009-9236(95)90154-X. [DOI] [PubMed] [Google Scholar]
  2. Anandatheerthavarada H. K., Boyd M. R., Ravindranath V. Characterization of a phenobarbital-inducible cytochrome P-450, NADPH-cytochrome P-450 reductase and reconstituted cytochrome P-450 mono-oxygenase system from rat brain. Evidence for constitutive presence in rat and human brain. Biochem J. 1992 Dec 1;288(Pt 2):483–488. doi: 10.1042/bj2880483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Anandatheerthavarada H. K., Shankar S. K., Ravindranath V. Rat brain cytochromes P-450: catalytic, immunochemical properties and inducibility of multiple forms. Brain Res. 1990 Dec 17;536(1-2):339–343. doi: 10.1016/0006-8993(90)90047-f. [DOI] [PubMed] [Google Scholar]
  4. Armstrong M., Daly A. K., Cholerton S., Bateman D. N., Idle J. R. Mutant debrisoquine hydroxylation genes in Parkinson's disease. Lancet. 1992 Apr 25;339(8800):1017–1018. doi: 10.1016/0140-6736(92)90537-d. [DOI] [PubMed] [Google Scholar]
  5. Bhagwat S. V., Boyd M. R., Ravindranath V. Brain mitochondrial cytochromes P450: xenobiotic metabolism, presence of multiple forms and their selective inducibility. Arch Biochem Biophys. 1995 Jun 20;320(1):73–83. doi: 10.1006/abbi.1995.1344. [DOI] [PubMed] [Google Scholar]
  6. Bhagwat S. V., Leelavathi B. C., Shankar S. K., Boyd M. R., Ravindranath V. Cytochrome P450 and associated monooxygenase activities in the rat and human spinal cord: induction, immunological characterization and immunocytochemical localization. Neuroscience. 1995 Sep;68(2):593–601. doi: 10.1016/0306-4522(95)00071-p. [DOI] [PubMed] [Google Scholar]
  7. Bhamre S., Anandatheerthavarada H. K., Shankar S. K., Ravindranath V. Microsomal cytochrome P450 in human brain regions. Biochem Pharmacol. 1992 Sep 25;44(6):1223–1225. doi: 10.1016/0006-2952(92)90390-5. [DOI] [PubMed] [Google Scholar]
  8. Bhattacharyya K. K., Brake P. B., Eltom S. E., Otto S. A., Jefcoate C. R. Identification of a rat adrenal cytochrome P450 active in polycyclic hydrocarbon metabolism as rat CYP1B1. Demonstration of a unique tissue-specific pattern of hormonal and aryl hydrocarbon receptor-linked regulation. J Biol Chem. 1995 May 12;270(19):11595–11602. doi: 10.1074/jbc.270.19.11595. [DOI] [PubMed] [Google Scholar]
  9. Britto M. R., Wedlund P. J. Cytochrome P-450 in the brain. Potential evolutionary and therapeutic relevance of localization of drug-metabolizing enzymes. Drug Metab Dispos. 1992 May-Jun;20(3):446–450. [PubMed] [Google Scholar]
  10. Coleman T., Ellis S. W., Martin I. J., Lennard M. S., Tucker G. T. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is N-demethylated by cytochromes P450 2D6, 1A2 and 3A4--implications for susceptibility to Parkinson's disease. J Pharmacol Exp Ther. 1996 May;277(2):685–690. [PubMed] [Google Scholar]
  11. Denison M. S., Whitlock J. P., Jr Xenobiotic-inducible transcription of cytochrome P450 genes. J Biol Chem. 1995 Aug 4;270(31):18175–18178. doi: 10.1074/jbc.270.31.18175. [DOI] [PubMed] [Google Scholar]
  12. Farin F. M., Omiecinski C. J. Regiospecific expression of cytochrome P-450s and microsomal epoxide hydrolase in human brain tissue. J Toxicol Environ Health. 1993 Oct-Nov;40(2-3):317–335. doi: 10.1080/15287399309531797. [DOI] [PubMed] [Google Scholar]
  13. Ghersi-Egea J. F., Perrin R., Leininger-Muller B., Grassiot M. C., Jeandel C., Floquet J., Cuny G., Siest G., Minn A. Subcellular localization of cytochrome P450, and activities of several enzymes responsible for drug metabolism in the human brain. Biochem Pharmacol. 1993 Feb 9;45(3):647–658. doi: 10.1016/0006-2952(93)90139-n. [DOI] [PubMed] [Google Scholar]
  14. Gilham D. E., Cairns W., Paine M. J., Modi S., Poulsom R., Roberts G. C., Wolf C. R. Metabolism of MPTP by cytochrome P4502D6 and the demonstration of 2D6 mRNA in human foetal and adult brain by in situ hybridization. Xenobiotica. 1997 Jan;27(1):111–125. doi: 10.1080/004982597240802. [DOI] [PubMed] [Google Scholar]
  15. Gonzalez F. J. Human cytochromes P450: problems and prospects. Trends Pharmacol Sci. 1992 Sep;13(9):346–352. doi: 10.1016/0165-6147(92)90107-h. [DOI] [PubMed] [Google Scholar]
  16. Guengerich F. P. Human cytochrome P-450 enzymes. Life Sci. 1992;50(20):1471–1478. doi: 10.1016/0024-3205(92)90136-d. [DOI] [PubMed] [Google Scholar]
  17. Hakkola J., Pasanen M., Pelkonen O., Hukkanen J., Evisalmi S., Anttila S., Rane A., Mäntylä M., Purkunen R., Saarikoski S. Expression of CYP1B1 in human adult and fetal tissues and differential inducibility of CYP1B1 and CYP1A1 by Ah receptor ligands in human placenta and cultured cells. Carcinogenesis. 1997 Feb;18(2):391–397. doi: 10.1093/carcin/18.2.391. [DOI] [PubMed] [Google Scholar]
  18. Herkenham M., Little M. D., Bankiewicz K., Yang S. C., Markey S. P., Johannessen J. N. Selective retention of MPP+ within the monoaminergic systems of the primate brain following MPTP administration: an in vivo autoradiographic study. Neuroscience. 1991;40(1):133–158. doi: 10.1016/0306-4522(91)90180-v. [DOI] [PubMed] [Google Scholar]
  19. Herkenham M., Little M. D., Bankiewicz K., Yang S. C., Markey S. P., Johannessen J. N. Selective retention of MPP+ within the monoaminergic systems of the primate brain following MPTP administration: an in vivo autoradiographic study. Neuroscience. 1991;40(1):133–158. doi: 10.1016/0306-4522(91)90180-v. [DOI] [PubMed] [Google Scholar]
  20. Hirvonen A. Genetic factors in individual responses to environmental exposures. J Occup Environ Med. 1995 Jan;37(1):37–43. doi: 10.1097/00043764-199501000-00006. [DOI] [PubMed] [Google Scholar]
  21. Iscan M., Reuhl K., Weiss B., Maines M. D. Regional and subcellular distribution of cytochrome P-450-dependent drug metabolism in monkey brain: the olfactory bulb and the mitochondrial fraction have high levels of activity. Biochem Biophys Res Commun. 1990 Jun 29;169(3):858–863. doi: 10.1016/0006-291x(90)91972-u. [DOI] [PubMed] [Google Scholar]
  22. Mills J. C., Nelson D., Erecińska M., Pittman R. N. Metabolic and energetic changes during apoptosis in neural cells. J Neurochem. 1995 Oct;65(4):1721–1730. doi: 10.1046/j.1471-4159.1995.65041721.x. [DOI] [PubMed] [Google Scholar]
  23. Montoliu C., Sancho-Tello M., Azorin I., Burgal M., Vallés S., Renau-Piqueras J., Guerri C. Ethanol increases cytochrome P4502E1 and induces oxidative stress in astrocytes. J Neurochem. 1995 Dec;65(6):2561–2570. doi: 10.1046/j.1471-4159.1995.65062561.x. [DOI] [PubMed] [Google Scholar]
  24. Murray G. I., Taylor M. C., McFadyen M. C., McKay J. A., Greenlee W. F., Burke M. D., Melvin W. T. Tumor-specific expression of cytochrome P450 CYP1B1. Cancer Res. 1997 Jul 15;57(14):3026–3031. [PubMed] [Google Scholar]
  25. Narimatsu S., Tachibana M., Masubuchi Y., Suzuki T. Cytochrome P4502D and -2C enzymes catalyze the oxidative N-demethylation of the parkinsonism-inducing substance 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in rat liver microsomes. Chem Res Toxicol. 1996 Jan-Feb;9(1):93–98. doi: 10.1021/tx9500540. [DOI] [PubMed] [Google Scholar]
  26. Nebert D. W., Gonzalez F. J. P450 genes: structure, evolution, and regulation. Annu Rev Biochem. 1987;56:945–993. doi: 10.1146/annurev.bi.56.070187.004501. [DOI] [PubMed] [Google Scholar]
  27. Nebert D. W., Nelson D. R., Coon M. J., Estabrook R. W., Feyereisen R., Fujii-Kuriyama Y., Gonzalez F. J., Guengerich F. P., Gunsalus I. C., Johnson E. F. The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature. DNA Cell Biol. 1991 Jan-Feb;10(1):1–14. doi: 10.1089/dna.1991.10.1. [DOI] [PubMed] [Google Scholar]
  28. Otto S., Marcus C., Pidgeon C., Jefcoate C. A novel adrenocorticotropin-inducible cytochrome P450 from rat adrenal microsomes catalyzes polycyclic aromatic hydrocarbon metabolism. Endocrinology. 1991 Aug;129(2):970–982. doi: 10.1210/endo-129-2-970. [DOI] [PubMed] [Google Scholar]
  29. Pai K. S., Ravindranath V. Protection and potentiation of MPTP-induced toxicity by cytochrome P-450 inhibitors and inducer: in vitro studies with brain slices. Brain Res. 1991 Aug 2;555(2):239–244. doi: 10.1016/0006-8993(91)90347-x. [DOI] [PubMed] [Google Scholar]
  30. Przedborski S., Levivier M., Jiang H., Ferreira M., Jackson-Lewis V., Donaldson D., Togasaki D. M. Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine. Neuroscience. 1995 Aug;67(3):631–647. doi: 10.1016/0306-4522(95)00066-r. [DOI] [PubMed] [Google Scholar]
  31. Przedborski S., Levivier M., Jiang H., Ferreira M., Jackson-Lewis V., Donaldson D., Togasaki D. M. Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine. Neuroscience. 1995 Aug;67(3):631–647. doi: 10.1016/0306-4522(95)00066-r. [DOI] [PubMed] [Google Scholar]
  32. Ravindranath V., Anandatheerthavarada H. K., Shankar S. K. Xenobiotic metabolism in human brain--presence of cytochrome P-450 and associated mono-oxygenases. Brain Res. 1989 Sep 4;496(1-2):331–335. doi: 10.1016/0006-8993(89)91083-4. [DOI] [PubMed] [Google Scholar]
  33. Ravindranath V., Bhamre S., Bhagwat S. V., Anandatheerthavarada H. K., Shankar S. K., Tirumalai P. S. Xenobiotic metabolism in brain. Toxicol Lett. 1995 Dec;82-83:633–638. doi: 10.1016/0378-4274(95)03508-7. [DOI] [PubMed] [Google Scholar]
  34. Riedl A. G., Watts P. M., Edwards R. J., Boobis A. R., Jenner P., Marsden C. D. Selective localisation of P450 enzymes and NADPH-P450 oxidoreductase in rat basal ganglia using anti-peptide antisera. Brain Res. 1996 Dec 16;743(1-2):324–328. doi: 10.1016/s0006-8993(96)00746-9. [DOI] [PubMed] [Google Scholar]
  35. Schilter B., Omiecinski C. J. Regional distribution and expression modulation of cytochrome P-450 and epoxide hydrolase mRNAs in the rat brain. Mol Pharmacol. 1993 Nov;44(5):990–996. [PubMed] [Google Scholar]
  36. Shimada T., Hayes C. L., Yamazaki H., Amin S., Hecht S. S., Guengerich F. P., Sutter T. R. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res. 1996 Jul 1;56(13):2979–2984. [PubMed] [Google Scholar]
  37. Smith C. A., Gough A. C., Leigh P. N., Summers B. A., Harding A. E., Maraganore D. M., Sturman S. G., Schapira A. H., Williams A. C., Maranganore D. M. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet. 1992 Jun 6;339(8806):1375–1377. doi: 10.1016/0140-6736(92)91196-f. [DOI] [PubMed] [Google Scholar]
  38. Spink D. C., Hayes C. L., Young N. R., Christou M., Sutter T. R., Jefcoate C. R., Gierthy J. F. The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on estrogen metabolism in MCF-7 breast cancer cells: evidence for induction of a novel 17 beta-estradiol 4-hydroxylase. J Steroid Biochem Mol Biol. 1994 Dec;51(5-6):251–258. doi: 10.1016/0960-0760(94)90037-x. [DOI] [PubMed] [Google Scholar]
  39. Sriram K., Pai K. S., Ravindranath V. Protection and potentiation of 1-methyl-4-phenylpyridinium-induced toxicity by cytochrome P450 inhibitors and inducer may be due to the altered uptake of the toxin. J Neurochem. 1995 Mar;64(3):1203–1208. doi: 10.1046/j.1471-4159.1995.64031203.x. [DOI] [PubMed] [Google Scholar]
  40. Sutter T. R., Tang Y. M., Hayes C. L., Wo Y. Y., Jabs E. W., Li X., Yin H., Cody C. W., Greenlee W. F. Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J Biol Chem. 1994 May 6;269(18):13092–13099. [PubMed] [Google Scholar]
  41. Takakubo F., Yamamoto M., Ogawa N., Yamashita Y., Mizuno Y., Kondo I. Genetic association between cytochrome P450IA1 gene and susceptibility to Parkinson's disease. J Neural Transm (Vienna) 1996;103(7):843–849. doi: 10.1007/BF01273362. [DOI] [PubMed] [Google Scholar]
  42. Tang Y. M., Wo Y. Y., Stewart J., Hawkins A. L., Griffin C. A., Sutter T. R., Greenlee W. F. Isolation and characterization of the human cytochrome P450 CYP1B1 gene. J Biol Chem. 1996 Nov 8;271(45):28324–28330. doi: 10.1074/jbc.271.45.28324. [DOI] [PubMed] [Google Scholar]
  43. Walker N. J., Gastel J. A., Costa L. T., Clark G. C., Lucier G. W., Sutter T. R. Rat CYP1B1: an adrenal cytochrome P450 that exhibits sex-dependent expression in livers and kidneys of TCDD-treated animals. Carcinogenesis. 1995 Jun;16(6):1319–1327. doi: 10.1093/carcin/16.6.1319. [DOI] [PubMed] [Google Scholar]
  44. Walther B., Ghersi-Egea J. F., Jayyosi Z., Minn A., Siest G. Ethoxyresorufin O-deethylase activity in rat brain subcellular fractions. Neurosci Lett. 1987 Apr 23;76(1):58–62. doi: 10.1016/0304-3940(87)90192-3. [DOI] [PubMed] [Google Scholar]
  45. Walther B., Ghersi-Egea J. F., Minn A., Siest G. Subcellular distribution of cytochrome P-450 in the brain. Brain Res. 1986 Jun 11;375(2):338–344. doi: 10.1016/0006-8993(86)90754-7. [DOI] [PubMed] [Google Scholar]

Articles from Molecular Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES